Table 2.

Most frequently reported side effects: Comparison of women treated for BC with GP

	Injection site soreness	Fatigue	Generalized muscle soreness (GMS)	Headache	Chills
Dose 1	76.0% BC	42.7% BC	23.0% BC	18.4% BC	9.5% BC
	82.4% GP	38.1% GP	21.7% GP	33.1% GP	8.8% GP
Dose 2	76.2% BC	59.3% BC	31.9% BC	32.4% BC	23.7% BC
	85.0% GP	63.2% GP	52.5% GP	55.9% GP	40.8% GP

*BC = women treated for breast cancer (n = 621 Dose 1, n = 621 Dose 2)

*GP = general population reported by NEJM (n = 19256 Dose 1, n = 17702 Dose 2)